市場調查報告書
商品編碼
1470585
CRISPR 技術市場:按產品、應用和最終用戶分類 - 2024-2030 年全球預測CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年CRISPR技術市場規模為32.5億美元,預計2024年將達到37.7億美元,2030年將達到94.9億美元,複合年成長率為16.52%。
成簇規則間隔短回文重複序列 (CRISPR) 是源自細菌防禦機制的高度精確且高效的基因組編輯工具,可對生物體基因組內的 DNA 序列進行有針對性的操作。這種創新的生物技術工具能夠利用 RNA 引導的 Cas9 核酸酶進行精確的基因組編輯,從而促進醫療保健、農業和生質能源產業的標靶基因修飾。研究活動資金的增加、基因治療的進步、遺傳病患病率的增加以及對更有效率作物生產方法的需求正在推動 CRISPR 技術的使用增加。然而,圍繞基因編輯(特別是在人類生殖細胞中)的倫理問題以及各個地區的監管障礙可能會阻礙 CRISPR 產品的採用和商業化。然而,藥物發現的進步包括創造具有更高營養價值和抗病蟲害能力的新型作物,以及使用 CRISPR 系統針對特定標靶篩檢大型化合物庫,為 CRISPR 創造了利潤豐厚的機會。
主要市場統計 | |
---|---|
基準年[2023] | 32.5億美元 |
預測年份 [2024] | 37.7億美元 |
預測年份 [2030] | 94.9億美元 |
複合年成長率(%) | 16.52% |
提供的 CRISPR套件和試劑的使用迅速增加,研究活動和產品改進取得進展
CRISPR 技術中使用的酵素是基因編輯的關鍵組件,其中 Cas9 是最常用的酵素。這些酵素充當分子剪刀,可以精確切割和修飾 DNA 序列。引導 RNA 對於引導 Cas 酶靶向細胞 DNA 序列中的特定基因組位置非常重要。研究人員可能需要針對特定目標設計的自訂gRNA,或者他們可能更喜歡預先設計的涵蓋模型生物或細胞株中常見基因目標的文庫。 CRISPR套件和試劑產品系列包括質體、Cas9蛋白、sgRNA(單嚮導RNA)、表達載體、同源定向修復(HDR)模板、病毒遞送系統(如腺結合病毒(AAV)和慢病毒)以及溶核產品包括基於電穿孔的轉染方法,包括轉染裝置和脂轉染試劑。細胞株工程服務利用CRISPR技術修飾細胞以引入或增強特定功能,使研究人員能夠研究基因功能並開發標靶治療。這項服務對於專門從事藥物發現、基因治療和再生醫學的生物製藥公司和學術機構至關重要。引導 RNA (gRNA) 和載體系統的設計和建構對於 CRISPR 介導的基因編輯實驗至關重要。研究人員依靠這些服務來產生高效、特異性的敲除或敲入模型,這對於功能基因組學、標靶檢驗研究和疾病建模等應用尤其重要。基於 CRISPR 的篩檢服務對於識別新藥物標靶和闡明生物途徑中重要的遺傳交互作用至關重要。
擴大CRISPR技術在農業領域的應用
在農業領域,CRISPR 技術為作物改良、抗病蟲害以及提高產量提供了解決方案。 CRISPR技術也應用於生物醫學研究,如遺傳疾病的基因治療、癌症免疫治療、感染疾病治療等。 CRISPR技術的工業應用包括微生物工程、生質燃料、生醫材料和環境生物修復。
最終用戶:CRISPR技術在生技公司的潛在應用
學術和政府研究機構主要專注於CRISPR技術的基礎研究和新應用的開發。他們對 CRISPR 的需求將產生先進的知識和工具,以了解基因編輯背後的機制,針對人類基因組中的特定基因,並找到各種遺傳疾病的潛在治療解決方案。使用 CRISPR 技術的生物技術公司專注於商業性應用的應用研究,例如最佳化工業、增強工業生物過程或直接向消費者銷售基因工程產品。製藥公司正在將 CRISPR 技術應用於治療,特別是針對遺傳性疾病、癌症和肥胖等文明病的藥物發現和藥物開發。
區域洞察
在美國,由於廣泛的研究和開發活動、公共和私營部門的大量投資以及生物資訊學的進步,CRISPR 技術市場正在經歷顯著成長。此外,農業、生物技術、藥物發現和治療等強勁且穩定成長的行業正在推動對 CRISPR 技術的需求。亞太地區擁有不斷成長的生物製藥產業,該產業正在大力投資基因編輯技術,以促進農業進步和疾病治療應用。此外,政府對基因組學研究的支持以及與國際組織的戰略聯盟等因素正在加速該地區的市場成長。由於其完善的製藥基礎設施和各個組織對基因組編輯研究計劃的資助,歐洲經歷了可觀的成長。此外,中東和非洲子區隔放在 CRISPR 在鐮鐮狀性貧血和 BETA 地中海貧血等疾病的治療應用。
FPNV定位矩陣
FPNV定位矩陣對於評估CRISPR技術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對 CRISPR 技術市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.CRISPR技術市場的市場規模與預測為何?
2.在CRISPR技術市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.CRISPR技術市場的技術趨勢和法規結構是什麼?
4. CRISPR技術市場主要廠商的市場佔有率是多少?
5.進入CRISPR技術市場的合適型態和策略手段是什麼?
[183 Pages Report] The CRISPR Technology Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 16.52% to reach USD 9.49 billion by 2030.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a highly precise and efficient genome-editing tool derived from a bacterial defense mechanism, which allows for targeted manipulation of the DNA sequence within an organism's genome. This innovative biotechnology tool enables precise genome editing through RNA-guided Cas9 nucleases, facilitating targeted genetic modifications across healthcare, agriculture, and bioenergy industries. Increased funding for research activities, advancements in gene therapy, the growing prevalence of genetic disorders, and the need for more efficient crop production methods increase the use of CRISPR technology. However, ethical concerns surrounding gene editing, especially in human germline cells, and regulatory hurdles in different regions may impede the adoption or commercialization of CRISPR products. Nevertheless, creating new genetically modified crops (GMO) with enhanced nutritional value or resistance to pests and diseases and advancing drug discovery by screening large libraries of compounds against specific targets using CRISPR systems creates lucrative opportunities for the CRISPR technology market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.25 billion |
Estimated Year [2024] | USD 3.77 billion |
Forecast Year [2030] | USD 9.49 billion |
CAGR (%) | 16.52% |
Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
The enzymes used in CRISPR technology are critical components for gene editing, with Cas9 being the most commonly utilized enzyme. These enzymes function as molecular scissors, enabling precise cutting and modification of DNA sequences. Guide RNAs have significance in directing the Cas enzymes to target specific genomic locations within a cell's DNA sequence. Researchers may require custom gRNAs designed for their particular targets or prefer pre-designed libraries that cover common gene targets in model organisms or cell lines. The CRISPR kits & reagent product portfolio comprises a range of products, including plasmids, Cas9 proteins, sgRNAs (single guide RNAs), expression vectors, homology-directed repair (HDR) templates, viral delivery systems such as adeno-associated viruses (AAV) or lentiviruses, electroporation-based transfection methods including nucleofection devices or lipofection reagents. Cell line engineering services involve modifying cells to introduce or enhance specific features using CRISPR technology, enabling researchers to study gene function and develop targeted therapies. This service is crucial for biopharmaceutical companies and academic institutions focused on drug discovery, gene therapy, and regenerative medicine. The design and construction of guide RNAs (gRNAs) and vector systems are essential in CRISPR-mediated gene editing experiments. Researchers rely on these services for generating knockout or knock-in models with high efficiency and specificity, which is particularly important in applications such as functional genomics, target validation studies, and disease modeling. CRISPR-based screening services are pivotal for identifying novel drug targets or uncovering critical genetic interactions within biological pathways.
Application: Proliferating use of CRISPR technology in the agricultural sector
In the agricultural sector, CRISPR technology provides solutions for crop improvement, pest and disease resistance, and increased yield. CRISPR technology has applications in biomedical research, such as gene therapy for genetic disorders, cancer immunotherapy, and infectious disease treatment. The industrial applications of CRISPR technology encompass microbial engineering, biofuels, biomaterials, and environmental bioremediation.
End-User: Potential application of CRISPR technology in biotechnology companies
Academic and government research institutes primarily focus on fundamental research and developing novel applications for CRISPR technology. Their need-based preference for CRISPR revolves around generating advanced knowledge and tools to understand the mechanism behind gene editing, targeting specific genes in the human genome, and finding potential therapeutic solutions for various genetic disorders. Biotechnology companies utilizing CRISPR technology focus on applied research with commercial applications such as agriculture optimization, industrial bioprocessing enhancement, or direct-to-consumer genetic modification products. Pharmaceutical companies involve therapeutic applications of CRISPR technology for drug discovery and development, specifically targeting genetic diseases, cancers, or lifestyle disorders such as obesity.
Regional Insights
In America, the CRISPR technology market represents significant growth due to extensive research and development activities, substantial investments by both public and private sectors, and advances in bioinformatics. In addition, robust and steadily growing sectors such as agriculture, biotechnology, drug discovery, and therapeutics increased demand for CRISPR technology. The APAC region boasts increasing biopharmaceutical industries investing heavily in gene-editing technologies for agricultural advancements and disease treatment applications. Additionally, factors such as government support for genomics research and strategic collaborations with international organizations have accelerated market growth in this region. Europe has experienced considerable growth due to its well-established pharmaceutical infrastructure and funding from various organizations for genome editing research projects. Moreover, the Middle-East and Africa sub-segments focus on therapeutic applications of CRISPR for diseases such as sickle cell anemia and beta-thalassemia.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the CRISPR Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CRISPR Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the CRISPR Technology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CRISPR Technology Market?
3. What are the technology trends and regulatory frameworks in the CRISPR Technology Market?
4. What is the market share of the leading vendors in the CRISPR Technology Market?
5. Which modes and strategic moves are suitable for entering the CRISPR Technology Market?